Ligands of Immunopharmacology

JC2-11 is an inhibitor of inflammatory corpuscles. JC2-11 inhibits domain-containing protein NLRC 4 , absent in melanoma 2 ( AIM 2 ) and non-canonical ( NC ) inflammatory corpuscles. JC2-11 reduces the secretion of caspase-1 ( p20 ), the cleavage of

JC2-11 is an inhibitor of inflammatory corpuscles. JC2-11 inhibits domain-containing protein NLRC 4 , absent in melanoma 2 ( AIM 2 ) and non-canonical ( NC ) inflammatory corpuscles. JC2-11 reduces the secretion of caspase-1 ( p20 ), the cleavage of

JC2-11 is an inhibitor of inflammatory corpuscles. JC2-11 inhibits domain-containing protein NLRC 4 , absent in melanoma 2 ( AIM 2 ) and non-canonical ( NC ) inflammatory corpuscles. JC2-11 reduces the secretion of caspase-1 ( p20 ), the cleavage of

JH-X-119-01 hydrochloride is a potent and selective interleukin-1 receptor-associated kinases 1 ( IRAK1 ) inhibitor. JH-X-119-01 hydrochloride ameliorates LPS-induced sepsis in miceIn VitroJh-X-119-01 (10 μM) decreases phosphorylation of NF-κB and

JH-X-119-01 hydrochloride is a potent and selective interleukin-1 receptor-associated kinases 1 ( IRAK1 ) inhibitor. JH-X-119-01 hydrochloride ameliorates LPS-induced sepsis in miceIn VitroJh-X-119-01 (10 μM) decreases phosphorylation of NF-κB and

JH-X-119-01 hydrochloride is a potent and selective interleukin-1 receptor-associated kinases 1 ( IRAK1 ) inhibitor. JH-X-119-01 hydrochloride ameliorates LPS-induced sepsis in miceIn VitroJh-X-119-01 (10 μM) decreases phosphorylation of NF-κB and

JH-X-119-01 hydrochloride is a potent and selective interleukin-1 receptor-associated kinases 1 ( IRAK1 ) inhibitor. JH-X-119-01 hydrochloride ameliorates LPS-induced sepsis in miceIn VitroJh-X-119-01 (10 μM) decreases phosphorylation of NF-κB and

JH-X-119-01 hydrochloride is a potent and selective interleukin-1 receptor-associated kinases 1 ( IRAK1 ) inhibitor. JH-X-119-01 hydrochloride ameliorates LPS-induced sepsis in miceIn VitroJh-X-119-01 (10 μM) decreases phosphorylation of NF-κB and

JNJ-1013 is a potent and selective IRAK1 degrader with an IC 50 s of 72, 443, 1071 nM for IRAK1 , IRAK4 , VHL FP respectively. JNJ-1013 induces Apoptosis and increases the expression of cleavaged PARP . JNJ-1013 decreases the expression IRAK1 ,

JNJ-1013 is a potent and selective IRAK1 degrader with an IC 50 s of 72, 443, 1071 nM for IRAK1 , IRAK4 , VHL FP respectively. JNJ-1013 induces Apoptosis and increases the expression of cleavaged PARP . JNJ-1013 decreases the expression IRAK1 ,

K145 hydrochloride is a selective, substrate-competitive and orally active SphK2 inhibitor with an IC 50 of 4.3 µM and a K i of 6.4 µM. K145 hydrochloride is inactive against SphK1 and other protein kinases. K145 hydrochloride induces cell apoptosis

K145 hydrochloride is a selective, substrate-competitive and orally active SphK2 inhibitor with an IC 50 of 4.3 µM and a K i of 6.4 µM. K145 hydrochloride is inactive against SphK1 and other protein kinases. K145 hydrochloride induces cell apoptosis